Leap Therapeutics (LPTX) Misses Q3 EPS by 44c
Tweet
Share
E-mailGet Alerts LPTX Hot Sheet
Join SI Premium – FREE
Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.44).
For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yatsen Holding (YSG) Reports Q2 Loss of $0.16
- MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
- NIQ and Similarweb to build AI commerce measurement tool
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
